| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
OBJECTIVE: To determine if suppressive acyclovir therapy given to term gravidas experiencing a first episode of genital herpes simplex virus (HSV)-infection during pregnancy decreases the need for cesarean delivery for that indication. METHODS: Forty-six pregnant women with first episodes of genital herpes during pregnancy were randomly assigned to receive oral acyclovir 400 mg or placebo, three times per day, from 36 weeks' gestation until delivery as part of a prospective, double-blind trial. Herpes simplex virus cultures were obtained when patients presented for delivery. Vaginal delivery was permitted if no clinical recurrence was present; otherwise, a cesarean was performed. Neonatal HSV cultures were obtained and infants were followed-up clinically. RESULTS: None of the 21 patients treated with acyclovir and nine of 25 (36%) treated with placebo had clinical evidence of recurrent genital herpes at delivery (odds ratio [OR] 0.04, 95% confidence interval [CI] 0.002-0.745; P = .002). No woman treated with acyclovir had a cesarean for herpes, compared with nine of 25 (36%) of those treated with placebo (OR 0.04, CI 0.002-0.745; P = .002). No patient in either treatment group experienced asymptomatic genital viral shedding at delivery. No neonate had evidence of herpes infection or adverse effects from acyclovir. CONCLUSION: Suppressive acyclovir therapy reduced the need for cesarean for recurrent herpes in women whose first clinical episode of genital HSV occurred during pregnancy. Suppressive acyclovir treatment did not increase asymptomatic viral shedding and was not harmful to the term fetus.
This article has been cited by other articles:
|
|
 |
|
  P Sen and S E Barton Genital herpes and its management BMJ, May 19, 2007; 334(7602): 1048 - 1052. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Caughey, A. C. Urato, and P. Lurie Valacyclovir Prophylaxis to Prevent Recurrent Herpes at Delivery: A Randomized Clinical Trial Obstet. Gynecol., December 1, 2006; 108(6): 1550 - 1550. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. Kropp, T. Wong, L. Cormier, A. Ringrose, S. Burton, J. E. Embree, and M. Steben Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics, June 1, 2006; 117(6): 1955 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. A. Brown, C. Gardella, A. Wald, R. A. Morrow, and L. Corey Genital Herpes Complicating Pregnancy Obstet. Gynecol., October 1, 2005; 106(4): 845 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Kimberlin and D. J. Rouse Genital Herpes N. Engl. J. Med., May 6, 2004; 350(19): 1970 - 1977. [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Kimberlin Neonatal Herpes Simplex Infection Clin. Microbiol. Rev., January 1, 2004; 17(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Brown Use of Herpes Type-specific Serology to Prevent Neonatal Herpes Simplex Virus Infection NeoReviews, January 1, 2004; 5(1): e16 - 21. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Sheffield, L. M. Hollier, J. B. Hill, G. S. Stuart, and G. D. Wendel Jr Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review Obstet. Gynecol., December 1, 2003; 102(6): 1396 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Brown, A. Wald, R. A. Morrow, S. Selke, J. Zeh, and L. Corey Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to Infant JAMA, January 8, 2003; 289(2): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R V Barnabas, H Carabin, and G P Garnett The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis Sex Transm Inf, December 1, 2002; 78(6): 425 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Balfour Antiviral Drugs N. Engl. J. Med., April 22, 1999; 340(16): 1255 - 1268. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
